Zinc Picolinate Market
The market for Zinc Picolinate was estimated at $173 million in 2024; it is anticipated to increase to $279 million by 2030, with projections indicating growth to around $416 million by 2035.
Global Zinc Picolinate Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Zinc Picolinate industry revenue is expected to be around $187.4 million in 2025 and expected to showcase growth with 8.3% CAGR between 2025 and 2034. Building on this projected trajectory, the zinc picolinate market continues to gain importance within the global nutraceutical and dietary supplement industry. Increasing consumer awareness regarding micronutrient deficiencies and immune health is a key factor driving demand. The growing emphasis on preventive healthcare, particularly after recent global health concerns, has encouraged regular supplementation practices across diverse age groups. Additionally, the expansion of e-commerce platforms and direct-to-consumer brands is improving product accessibility and visibility. Manufacturers are also focusing on high-bioavailability mineral formulations to differentiate their offerings. Regulatory support for dietary supplements in various regions, combined with rising health-conscious populations, is reinforcing the market’s relevance and creating sustained demand across both developed and emerging economies.
Zinc picolinate is a highly bioavailable form of zinc, where the mineral is bound to picolinic acid to enhance absorption in the human body. It is widely used in dietary supplements to support immune function, metabolic activity, and overall cellular health. This compound is particularly valued for its superior absorption compared to other zinc salts, making it a preferred choice among healthcare professionals and supplement manufacturers. Major applications include immune support products, skin health formulations, and general wellness supplements. Recent trends driving demand include the rising popularity of personalized nutrition, clean-label supplements, and combination products that include vitamins and minerals for enhanced efficacy.
Market Key Insights
The Zinc Picolinate market is projected to grow from $173.0 million in 2024 to $384 million in 2034. This represents a CAGR of 8.3%, reflecting rising demand across Dietary Supplements, Immune Health Support, and Skincare Products.
NOW Foods, Thorne Research, Swanson Ultra are among the leading players in this market, shaping its competitive landscape.
U.S. and Germany are the top markets within the Zinc Picolinate market and are expected to observe the growth CAGR of 6.1% to 8.7% between 2024 and 2030.
Emerging markets including India, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 8.0% to 10.4%.
Transition like Transition from generic mineral supplementation to high-bioavailability premium nutraceutical formulations is expected to add $27 million to the Zinc Picolinate market growth by 2030.
The Zinc Picolinate market is set to add $211 million between 2024 and 2034, with manufacturer targeting medicinal Use Application projected to gain a larger market share.
With
increased demand for immune boosting supplements, and
Rising Interest in Bioavailable Nutritional Supplements, Zinc Picolinate market to expand 122% between 2024 and 2034.